{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:02:30Z","timestamp":1780322550318,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.ahj.2008.02.006","type":"journal-article","created":{"date-parts":[[2008,4,26]],"date-time":"2008-04-26T11:09:02Z","timestamp":1209208142000},"page":"135-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["One-year clinical outcome after abciximab bolus-only compared with abciximab bolus and 12-hour infusion in the Randomized EArly Discharge after Transradial Stenting of CoronarY Arteries (EASY) Study"],"prefix":"10.1016","volume":"156","clinical-trial-number":[{"clinical-trial-number":"nct001169819","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Olivier F.","family":"Bertrand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Rod\u00e9s-Cabau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9ric","family":"Larose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can Manh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"D\u00e9ry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Courtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Nault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Costerousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"De Larochelli\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2008.02.006_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9343(02)01145-2","article-title":"Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization","volume":"113","author":"Topol","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2008.02.006_bib2","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199404073301402","article-title":"Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation","volume":"330","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.02.006_bib3","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1161\/CIRCULATIONAHA.106.638627","article-title":"A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation","volume":"114","author":"Bertrand","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.02.006_bib4","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/S0735-1097(01)01702-8","volume":"38","author":"Cannon","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2008.02.006_bib5","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jama.295.13.joc60034","article-title":"Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial","volume":"295","author":"Kastrati","year":"2006","journal-title":"Jama"},{"key":"10.1016\/j.ahj.2008.02.006_bib6","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa031859","article-title":"A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel","volume":"350","author":"Kastrati","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.02.006_bib7","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1161\/01.CIR.90.4.1757","article-title":"Pharmacodynamics of chimeric glycoprotein IIb\/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty","volume":"90","author":"Tcheng","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.02.006_bib8","first-page":"487","article-title":"High-dose, single-bolus eptifibatide: a safe and cost-effective alternative to conventional glycoprotein IIb\/IIIa inhibitor use for elective coronary interventions","volume":"18","author":"Fischell","year":"2006","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.ahj.2008.02.006_bib9","first-page":"521","article-title":"Bolus-only platelet glycoprotein IIb-IIIa inhibition during percutaneous coronary intervention","volume":"18","author":"Marmur","year":"2006","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.ahj.2008.02.006_bib10","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ahj.2006.04.035","article-title":"Benefit of bolus-only platelet glycoprotein IIb\/IIIa inhibition during percutaneous coronary intervention: insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial","volume":"152","author":"Marmur","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2008.02.006_bib11","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2008.02.006_bib12","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.jacc.2004.08.060","article-title":"Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization","volume":"44","author":"Kandzari","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2008.02.006_bib13","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1161\/01.CIR.0000137972.74120.12","article-title":"Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy","volume":"110","author":"Kastrati","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.02.006_bib14","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jacc.2005.10.047","article-title":"Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention","volume":"47","author":"Steinhubl","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2008.02.006_bib15","doi-asserted-by":"crossref","unstructured":"Assali AR, Salloum J, Sdringola S, et al. Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb\/IIIa inhibitors (abciximab or tirofiban). Am J Cardiol 2001;88:884-6, A6.","DOI":"10.1016\/S0002-9149(01)01897-5"},{"key":"10.1016\/j.ahj.2008.02.006_bib16","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0735-1097(02)02014-4","article-title":"Effect of additional temporary glycoprotein IIb\/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial)","volume":"40","author":"Bonz","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2008.02.006_bib17","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0735-1097(03)00944-6","article-title":"Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoPro Give Similar Efficacy Outcome Trial (TARGET)","volume":"42","author":"Chan","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2008.02.006_bib18","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1161\/01.CIR.0000157138.02645.11","article-title":"Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading with Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study","volume":"111","author":"Gurbel","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.02.006_bib19","first-page":"e166","volume":"113","author":"Smith","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.02.006_bib20","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0735-1097(99)00635-X","article-title":"Effect of glycoprotein IIb\/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction","volume":"35","author":"Neumann","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2008.02.006_bib21","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(94)90007-8","article-title":"Randomised trial of coronary intervention with antibody against platelet IIb\/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators","volume":"343","author":"Topol","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2008.02.006_bib22","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0735-1097(01)01290-6","article-title":"Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention","volume":"37","author":"Anderson","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2008.02.006_bib23","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jama.292.6.696","article-title":"Long-term efficacy of bivalirudin and provisional glycoprotein IIb\/IIIa blockade vs heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial","volume":"292","author":"Lincoff","year":"2004","journal-title":"Jama"},{"key":"10.1016\/j.ahj.2008.02.006_bib24","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1093\/eurheartj\/ehi459","article-title":"Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up","volume":"26","author":"Mukherjee","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2008.02.006_bib25","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jacc.2007.02.027","article-title":"Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial","volume":"49","author":"Manoukian","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2008.02.006_bib26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0140-6736(07)60450-4","article-title":"Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial","volume":"369","author":"Stone","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2008.02.006_bib27","series-title":"Reopro (abciximab); solution for intravenous injection; chimeric monoclonal antiplatelet antibody","year":"1998"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870308001452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870308001452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:36:09Z","timestamp":1757568969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870308001452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0002870308001452"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2008.02.006","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One-year clinical outcome after abciximab bolus-only compared with abciximab bolus and 12-hour infusion in the Randomized EArly Discharge after Transradial Stenting of CoronarY Arteries (EASY) Study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2008.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}